SOPH sophiagenetics.com: יחס שווי שוק לערך בספרים
SOPHiA GENETICS SA (SOPH) automates DNA analysis for oncology detection via cloud-based AI, eliminating routine tasks for geneticists. A stable cash flow is ensured by high subscription loyalty among research centers. The stock price action captured below is accompanied by the recruitment of top data scientists through generous stock options. The current metric stands at 7.73, underscoring the company's status within the medtech solutions segment.
SOPH (SOPHiA GENETICS SA): פילוחים אנליטיים ודוחות לפי אינדיקטורים
The scalable cloud platform of SOPHiA GENETICS SA (SOPH) for genome analysis minimizes physical costs by shifting business value into intellectual capital. This indicator compares the market value of shares with net assets, reflecting the premium for technological potential, which allows for an assessment of changes in the overvaluation of balance sheet capital and the determination of the current entry point relative to historical lows.